Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shaun A. Fleming"'
Autor:
Wendy Stock, Thomas B. Alexander, Charles G. Mullighan, Amanda Jacobson, Su Young Kim, Lindsey Rosenwinkel, Deeksha Vishwamitra, Jeremy A. Ross, Yan Sun, John C. Pesko, Bo Tong, Michelle Schmidt, Mohamed Badawi, Chunxu Qu, Yaqi Zhao, Kathryn G. Roberts, Joseph T. Opferman, Robin Norris, Ryan J. Mattison, Shaun A. Fleming, Seong Lin Khaw, Susan I. Colace, Jessica Leonard, Theodore W. Laetsch, Ashish Bajel, Jeffrey E. Rubnitz, Elias Jabbour, Norman J. Lacayo, Vinod A. Pullarkat
Combining venetoclax, a selective BCL2 inhibitor, with low-dose navitoclax, a BCL-XL/BCL2 inhibitor, may allow targeting of both BCL2 and BCL-XL without dose-limiting thrombocytopenia associated with navitoclax monotherapy. The safety and preliminary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45bfde002b935bce0e2049afbee2a4b
https://doi.org/10.1158/2159-8290.c.6549358.v1
https://doi.org/10.1158/2159-8290.c.6549358.v1
Autor:
Wendy Stock, Thomas B. Alexander, Charles G. Mullighan, Amanda Jacobson, Su Young Kim, Lindsey Rosenwinkel, Deeksha Vishwamitra, Jeremy A. Ross, Yan Sun, John C. Pesko, Bo Tong, Michelle Schmidt, Mohamed Badawi, Chunxu Qu, Yaqi Zhao, Kathryn G. Roberts, Joseph T. Opferman, Robin Norris, Ryan J. Mattison, Shaun A. Fleming, Seong Lin Khaw, Susan I. Colace, Jessica Leonard, Theodore W. Laetsch, Ashish Bajel, Jeffrey E. Rubnitz, Elias Jabbour, Norman J. Lacayo, Vinod A. Pullarkat
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a7a73d874845837c5236e29615a265
https://doi.org/10.1158/2159-8290.22540348.v1
https://doi.org/10.1158/2159-8290.22540348.v1
Autor:
Tongted P. Das, Daniel North, Shaun A. Fleming, Joanne L.C. Tan, Adam Ivey, Nicholas J. Cummings, Andrew Spencer, Sushrut S. Patil, Jacqueline M.L. Widjaja, Michael I. Swain, Catherine Bourke, Maureen E. O'Brien, David S. Kliman, David J. Curtis
Publikováno v:
Transplantation and Cellular Therapy.